GlassScriptPhysician profile
Mehul P Patel
NPI 1467449595
$46,841.65
in general payments reported to CMS, 2019-2025
31 companies · $1,432 in 2025
The $1,432 reported for 2025 was more than what 78% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $42K · 2020: $607 · 2021: $300 · 2022: $1,035 · 2023: $640 · 2024: $1,029 · 2025: $1,432.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,100.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,100.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $36,467.96 | 2019-2024 | Xarelto |
| Novartis Pharmaceuticals Corporation | $4,972.72 | 2019-2025 | |
| Boston Scientific Corporation | $1,764.74 | 2019-2025 | General - Therapies, Latitude Communicator Power Supply, Watchman Flx |
| Medtronic Vascular, INC. | $393.86 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $371.18 | 2019-2025 | Tezspire, Farxiga |
| Boehringer Ingelheim Pharmaceuticals, INC. | $361.05 | 2024-2025 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $304.46 | 2019-2025 | Eliquis |
| Sanofi-Aventis U.S. LLC | $263.86 | 2019-2025 | |
| Medtronic, INC. | $250.27 | 2022-2023 | Abre |
| Abbott Laboratories | $245.83 | 2019-2025 | Aveir, Cardiomems |
| Novo Nordisk INC | $245.52 | 2022-2025 | |
| Amgen INC. | $198.05 | 2019-2025 | Repatha, Repatha |
| Pfizer INC. | $143.90 | 2019-2025 | |
| Shockwave Medical, INC | $120.05 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Edwards Lifesciences Corporation | $109.75 | 2020 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Heartflow, INC. | $104.77 | 2019 | |
| Merck Sharp & Dohme LLC | $82.10 | 2022-2025 | Verquvo |
| Actelion Pharmaceuticals US, INC. | $77.36 | 2019-2024 | Opsumit |
| Abbvie INC. | $55.14 | 2019 | |
| Siemens Medical Solutions USA, INC. | $43.95 | 2023-2025 | Diagnostic Ultrasound System |
| Bridgebio Pharma, INC. | $43.25 | 2025 | Attruby |
| Cvrx, INC. | $36.51 | 2024 | Barostim Neo System |
| Amarin Pharma, INC. | $35.20 | 2019-2020 | |
| Philips North America LLC | $21.97 | 2023 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $21.89 | 2025 | Lifevest |
| Bayer Healthcare Pharmaceuticals INC. | $20.86 | 2024 | |
| Esperion Therapeutics, INC. | $19.59 | 2025 | Nexletol |
| Scpharmaceuticals INC. | $18.51 | 2024 | |
| Endo Pharmaceuticals INC. | $17.73 | 2022 | |
| Janssen Biotech, INC. | $15.18 | 2024 | Erleada |
| Vivaquant INC, Dba Rhythm Express | $14.44 | 2025 | Rhythm Express |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mehul Patel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.